Amgen, Inc. (NASDAQ:AMGN)

CAPS Rating: 4 out of 5

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Recs

0
Player Avatar jncgator (< 20) Submitted: 8/22/2010 12:21:52 PM : Outperform Start Price: $51.32 AMGN Score: +11.43

The best buy in biotech

Report this Post Reply

Featured Broker Partners


Advertisement